Brooks C S, Johnson C A, Kotchen J M, Kotchen T A
Clin Pharmacol Ther. 1977 Jul;22(1):14-20. doi: 10.1002/cpt197722114.
This study was designed to compare the effectiveness of spironolactone, hydrochlorothiazide, and combined spironolactone-hydrochlorothiazide therapy in patients with low renin and those with normal renin essential hypertension. Patients with low renin hypertension had a greater hypotensive response to each regimen (p less than 0.001). Low renin patients responded equally to both spironolactone and to hydrochlorothiazide, and in low renin but not in normal renin patients reduction of blood pressure correlated with weight loss. These results suggest that a volume factor, not specifically related to increased mineralocorticoid production, contributes to the pathogenesis of low renin essential hypertension.
本研究旨在比较螺内酯、氢氯噻嗪以及螺内酯 - 氢氯噻嗪联合疗法对低肾素型和正常肾素型原发性高血压患者的疗效。低肾素型高血压患者对每种治疗方案的降压反应更强(p < 0.001)。低肾素型患者对螺内酯和氢氯噻嗪的反应相同,在低肾素型而非正常肾素型患者中,血压降低与体重减轻相关。这些结果表明,一个并非特异性与盐皮质激素生成增加相关的容量因素,参与了低肾素型原发性高血压的发病机制。